Blanket Purchase Agreement V797D50564-36E79724A0017
Award Date
5/29/24
Last Date to Order
5/28/25
Federal Agency
National Acquisition Center
Awardee
Mayne Pharma Commercial LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs' National Acquisition Center to Mayne Pharma Commercial LLC, doing business as Mayne Pharma, for the procurement of halobetasol and tazaroten pharmaceuticals. The multiple-award FSS contract has a ceiling value of $5,000,000.00 and a period of performance through August 31, 2025. The contract also includes a single-award Blanket Purchase Agreement (BPA) with a ceiling value of $5,216,518.00 and a period...
This Blanket Purchase Agreement (BPA) contract was awarded by the National Acquisition Center, a civilian federal agency, to Merz Pharmaceuticals, LLC, a for-profit foreign-owned organization. The BPA is established under the GSA Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs, with a ceiling value of $12,057,300.00 and a period of performance running through March 12, 2026. The purpose of this BPA is to provide the agency with the pharmaceutical products Ampyra and Inbrijia. No...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Acer Therapeutics Inc. The contract has a ceiling value of $1,891,583.25 and a period of performance through July 7, 2026. The BPA is for the procurement of MIPLYFFA and OLPRUVA, two pharmaceutical products. No set-asides were used, and this was a single-award contract. The contract vehicle is based on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to HRA Pharma America, Inc. as the prime contractor. The BPA has a period of performance from June 10, 2025 to June 9, 2026 and a ceiling value of $1,386,062.00. The BPA is for the procurement of the pharmaceutical products Lysodren and Metopirone. No set-asides were used for this single-award contract. The purpose of this BPA is to establish a contract vehicle through which the...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency, to Civica Inc., a non-profit organization and manufacturer of goods. The BPA has a ceiling value of $625,000.00 and a period of performance ending on April 3, 2026. The BPA is for the procurement of the pharmaceutical products daptomycin, lorazepam, phenylephrine, and anectine. As a BPA, this contract vehicle allows the agency to place individual task orders for these products as needed...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The BPA has a ceiling value of $118,500,000 and a period of performance from August 2024 to August 2026, with an option year extending it to August 2027. The BPA is for the procurement of specialized pharmaceutical products, primarily focused on medications for the treatment of rare diseases and pulmonary...
The Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Astellas Pharma US, Inc., a foreign-owned pharmaceutical manufacturer. The BPA is for the procurement of the oncology drugs XTANDI and XOSPATA, with a total ceiling value of $296,500 and a period of performance through October 2026. This BPA was established against Astellas' Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The agency has previously utilized...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency within the U.S. federal government, to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of specialized pharmaceutical products. The BPA, valued at $131,039,520.00, is a single-award contract that falls under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. It enables the procurement of various critical medications such as CINRYZE,...
The Blanket Purchase Agreement (BPA) is a single-award federal contract indefinite delivery vehicle (IDV) awarded by the National Acquisition Center, a civilian agency, to UCB, Inc. (UEI F3N9Q9TY2BC9), doing business as UCB Pharma, Inc. The BPA, valued at $264,295.45, is established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a performance period through September 2025. The primary purpose of the BPA is to provide the Department of Veterans Affairs (VA) with...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Fera Pharmaceuticals, LLC, a woman-owned small business. The BPA, valued at up to $255,000, is for the procurement of Phospholine Iodide, a pharmaceutical drug. The BPA was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and allows the VA and other agencies to efficiently and compliantly acquire the needed pharmaceutical product from Fera...